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The Nurses’ Health Study, a cohort of 121 701 female registered nurses, 
was established in 1976 to prospectively address the relationship between 
the use of oral contraceptives and the risk of breast cancer. Through follow-
up questionnaires every 2 years, exposures have been updated and new 
exposure assessments added. Repeated measures have allowed a broad 
range of analyses, including change measures and risk according to time 
since exposure. Responding to emerging public health issues and accessing 
new measures (such as exposure to silicone implants, air pollution and 
the built environment) has allowed investigators to address an evolving 
spectrum of topics. Prospective data on a wide range of chronic conditions 
have allowed assessment of preventable fractions of diseases, development 
of risk prediction models, and other applications that bring data to bear on 
translation of epidemiologic findings to health policy and practice. The aim 
of this report is to highlight the features of the Nurses’ Health Study and 
other cohorts that demonstrate continuing contributions to the changing 
epidemiology of chronic conditions.
Introduction
The Nurses’ Health Study began in the US in 1976 and continues 40 years 
later. This paper summarises a few examples of how the cohort has adapted 
to changing public health issues and how it continues to contribute across a 
broad range of health conditions.
We have previously addressed the use of data from cohort studies such as 
the Nurses’ Health Study to address the overall impact of the National Cancer 
Institute–funded research program in cancer epidemiology.1 In particular, we 
focused on the phases of the discovery, development and delivery paradigm 
of cancer research. Evidence from prospective cohort studies can help to 
explain the aetiology of disease with fewer sources of bias than retrospective 
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• Historically, many cohorts depend on a 
single baseline questionnaire to assess 
exposures. By continuing to contact 
participants and update exposure 
measures, the Nurses’ Health Study has 
allowed the addition of new exposures 
that address emerging public health 
issues. This has set the standard for more 
contemporary cohort studies
• Repeated measures allowed the study of 
change and time from exposure in relation 
to the changing risk of disease or benefits 
of prevention
• Documenting incident cases of many 
diseases, beyond the original focus on 
cancer, gives richer insights into women’s 
health and wellbeing as they age, 
demonstrating the risks and benefits of 
potential prevention interventions
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studies. However, tracing research reports to their use 
as part of the scientific evidence base – to inform social 
strategies to reduce the burden of disease and improve 
population health – is less well developed. Using this 
approach, we showed that the evidence from the study 
has contributed to the International Agency for Research 
on Cancer reports on alcohol and cancer, exogenous 
hormones and breast cancer, and to numerous reports 
of the US Surgeon General.1 These outcomes may be 
expected of a well-conducted cohort study contributing to 
the establishment of causality.
The Nurses’ Health Study cohort was established in 
1976 to evaluate risks to women’s health, including the 
relationships between oral contraceptives and breast 
cancer risk; exogenous hormone therapy and breast 
cancer risk; and smoking, hair dyes and cancer risk. 
However, the cohort has evolved to address a broad 
range of lifestyle factors, such as exposure to silicone 
implants, air pollution and the built environment.2 The 
addition of biological samples allowed the research to 
expand to study biomarkers of exposure to, for example, 
diet, hormones and trace elements2 (see Figure 1). The 
study also expanded from an original focus on cancer to 
include cardiovascular disease (CVD), type 2 diabetes, 
fractures, rheumatologic conditions and other outcomes 
of interest in women’s health. This expansion required 
funders to accept a core role for the National Cancer 
Institute and secondary roles for other funding bodies.
Responding to public health 
issues
The development of the Nurses’ Health Study included 
responding to public health issues. Additional important 
questions that were brought to the cohort included 
whether silicone breast implants increased the risk 
of connective tissue diseases. Dr Matthew Liang, a 
rheumatologist and colleague at Harvard Medical School, 
after attending a Food and Drug Administration hearing 
about implants, asked the investigators if the Nurses’ 
Health Study might address the issue prospectively. 
Figure 1.	 Evolution	of	the	Nurses’	Health	Study
FFQ = food frequency questionnaire; NHS = Nurses’ Health Study; SF-36 = 36-Item Short Form Health Survey
2000
Cheek cells collected from 35 000 participants
1999
Second blood and first urine collection
1996
Growing Up Today Study – 16 000 children (10–14) of women 
in NHS II recruited to study of diet activity and weight gain
1992
SF-36, Berkman–Syme Social Network Index added to follow-up
1988
Funding for collection of weight history 




Optical scanning of questionnaires 
implemented for increased efficiency
1978
Developed FFQ
Funding for follow-up of cohort
1997
Adolescent diet assessed among participants in NHS II
1994
Mothers of NHS participants study began
1989
Collected blood samples from 33 000 participants
NHS II began
1987
Funding for pilot development of blood collection
Funding for a study on benign breast disease and 
risk of breast cancer in the NHS cohort
1983
Toenails collected from 63 000 participants
1980
FFQ included in follow-up mailing to cohort
1976
Initial questionnaire mailed to NHS participants
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Dr Liang had already collaborated on confirmation 
of rheumatologic conditions within the cohort. By 
1992, 109 750 women were still participating in the 
study. Among many other topics in the 1992 biennial 
questionnaire, we asked participants if they had ever had 
breast implant surgery, or silicone, paraffin or collagen 
injections. Of the 89 376 women (81.4%) who returned 
the questionnaire, 88 153 answered the questions about 
breast implants and injections. We sent a supplementary 
questionnaire to obtain details about type of implant 
and indications to the 1861 women who reported having 
breast implants, or any sort or silicone, paraffin or 
collagen injections. Overall, we observed no association 
between implants and incidence of connective 
tissue diseases.3 
Other exposures that are not readily assessed through 
intervention studies and, hence, require observational 
designs include rotating shift work. The Nurses’ Health 
Study represented a unique resource – a cohort of nurses 
who had a personal history of shift work. Participants had 
all been trained as registered nurses before enrolment 
and many continued to participate in the workforce. In 
1988, we assessed the total number of years participants 
had worked rotating shift work. We showed a significant 
relationship between more years of rotating night shift 
work and risk of coronary heart disease (6 or more years 
of shift work vs never worked shift work: RR 1.51; 95% CI 
1.12, 2.03)4, increased risk of breast cancer with a trend 
of increasing risk with increasing years of rotating night 
shifts (30 or more years of shift work vs never worked shift 
work: RR 1.36; CI 1.04, 1.78)5, and an equal increase in 
the risk for colorectal cancer.6
Repeated measures
One important feature of the cohort follow-up has been 
the repeated assessment of exposure over time to, 
for example, weight fluctuations, tobacco smoke and 
diet. The cohort has enabled detailed assessment of 
the impact of weight change across the lifecourse – 
partitioning weight change from age 18 to current age 
(if premenopausal) or to menopause, and then change 
after menopause among postmenopausal women. 
We showed that weight loss after menopause was 
associated with a reduction in the risk of breast cancer. 
There was also a clear relationship between smoking 
cessation (and remaining a nonsmoker) and change 
in total mortality by time since quitting7, and data are 
not confounded by smoking recidivism (a factor that 
substantially underestimates the benefits of quitting in 
cohorts that do not update exposure status for smoking 
during follow-up). Changes in dietary patterns and 
nutrients over time allowed us to evaluate the changes 
in risk of CVD compared with those who did not change 
their diet quality. Compared with women who did not 
increase the quality of their diet, those who had the 
largest improvements in diet quality over 4 years had 
7–9% lower risk of CVD during the subsequent 4 years, 
and those whose diet quality worsened had a significantly 
increased risk of CVD.8 Diet validation data comparing 
food frequency questionnaires with diet records also 
allowed for development of methods to adjust for 
measurement error. 
Studies also distinguish time-course relationships 
between dietary exposures and outcomes, perhaps 
most fruitfully for colorectal cancer. By addressing the 
time from diet assessment of folate intake and risk of 
colorectal cancer, Lee et al.9 showed that a reduction in 
colorectal cancer was most evident 12–16 years after diet 
assessment, and that protection was reduced the shorter 
the follow-up from diet assessment. This confirmed 
that folate is operating earlier rather than later in the 
development of colorectal carcinogenesis. 
Risk models 
In the 1980s, using the data from the Nurses’ Health 
Study cohort, I was challenged by Dr Chris Bain to take 
the Pike model of breast cancer incidence10 – which 
states that breast tissue ageing begins at menarche, 
decreases after first birth and decreases further after 
menopause, and allows for an adverse effect of first 
pregnancy – and attempt to validate this model in the 
prospective cohort. We developed a lifecourse model 
of incidence, with risk accumulating at different rates 
corresponding to intervals defined by reproductive 
variables, menarche, age and spacing of births, and 
menopause, and according to weight and height across 
life. The 20 years of research has provided insights to 
the aetiology of breast cancer, allowed for the refined 
analysis of the interval from menarche to first full-term 
pregnancy (documenting the previous reports from case-
control studies that closer spacing of births, and not just 
the total number of pregnancies, lowers the risk) and 
helped to expand the field of risk prediction in cancer.11 
We noted that risk of benign breast disease accumulated 
particularly before menarche12, although we have not yet 
determined what lifestyle or environmental exposures 
are responsible for, or modify, this risk pathway to breast 
cancer. Expanding from the work of Armitage and Doll13, 
we also applied a lifecourse approach through log-
incidence modelling to ovarian cancer, melanoma and 
colorectal cancer risk prediction.
Expanding the scope 
In this section, I demonstrate the changing face of 
epidemiologic research during the past 40 years, and 
the adaptability required by researchers and funders to 
continue to address timely public health issues. Among 
the early changes in the conduct of epidemiological 
studies – and often followed by others – is the use of 
pathology samples to refine the understanding of disease 
aetiology.14 This first applied to benign breast lesions, but 
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after collection of tissue blocks from incident cases of 
invasive breast cancer and colon cancer, we applied a 
range of biomarker studies to better understand pathways 
and mechanisms from lifestyle to cancer aetiology and 
outcomes.15,16 This latter evaluation showed that a history 
of breastfeeding was inversely related to basal-like breast 
cancer.16 The cohort has also been a rich source of 
evidence on adiposity in childhood and its relationship 
to subsequent risk of breast cancer, where it is inversely 
related to oestrogen receptor–negative breast cancer.17
Studies of survivorship after cancer diagnosis and 
treatment were also an early addition to the ongoing 
cohort study. In part, this reflected the growing number 
of survivors in the population and a search for guidance 
on lifestyle after cancer. In 1992, we added measures of 
quality of life to the cohort follow-up questionnaire and 
then followed participants with repeated measures every 
4 years, enabling the quantification of change in quality 
of life after diagnosis of breast cancer, with the potential 
to control for prediagnostic values.18 Subsequent studies 
addressed physical activity and diet changes after 
cancer diagnosis, showing that higher levels of physical 
activity reduced risk of recurrence and death among 
women with breast and colorectal cancer.19 
Study participants live across the US, and this 
afforded opportunities to study the relationship between 
air pollution and health outcomes, while controlling for 
established causes such as smoking and blood pressure 
when assessing the incidence of CVD.20 In addition, we 
added measures of neighbourhood walkability to the 
underlying cohort data on individually assessed lifestyle 
measures. With these data, investigators have also 
assessed exposure to particulate air pollution, and the 
relationship between built environment, physical activity 
and body mass index. Air pollution and incidence of a 
broad range of chronic conditions were studied once 
the residential history and air quality data were linked 
and updated.
Another broad application of the cohort has been 
to determine the preventable burden of disease across 
multiple outcomes, from heart disease to diabetes and 
cancers. This again reflects both the power of the cohort 
and the richness achieved through detailed investigation 
of aetiology of many chronic conditions in women across 
middle and older ages. The wealth of data attest to the 
exogenous factors driving incidence of these chronic 
conditions in Western society.21
Conclusion 
The evolving focus on current issues of public health 
importance means investigators need to refine 
exposure measures that can be added to the cohort 
follow-up, particularly when repeated questionnaire 
assessments are a routine part of the cohort. Further, 
linking individual cohort member data to more group-
level measures – such as features of urban design 
and air pollution – that are now more readily available 
to investigators allows for timely focus on multilevel 
drivers of public health outcomes. The breadth of health 
conditions being documented and studied all add to 
the value of the Nurses’ Health Study as a model of a 
cohort study impacting public health policy and practice. 
Some findings translate to changes in regulation, such 
as transfat and its effect on heart disease and diabetes; 
others support prevention guidelines, such as aspirin and 
reduction in risk of colorectal cancer; and others guide 
recommendations by the US Surgeon General, such as 
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